According to Exelixis's latest financial reports the company's current revenue (TTM) is $1.84 B. In 2022 the company made a revenue of $1.61 B an increase over the years 2021 revenue that were of $1.43 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $1.83 B | 13.6% |
2022 | $1.61 B | 12.27% |
2021 | $1.43 B | 45.31% |
2020 | $0.98 B | 2.04% |
2019 | $0.96 B | 13.35% |
2018 | $0.85 B | 88.7% |
2017 | $0.45 B | 136.34% |
2016 | $0.19 B | 415.05% |
2015 | $37.17 M | 48.03% |
2014 | $25.11 M | -19.87% |
2013 | $31.33 M | -33.96% |
2012 | $47.45 M | -83.62% |
2011 | $0.28 B | 56.52% |
2010 | $0.18 B | 21.93% |
2009 | $0.15 B | 28.76% |
2008 | $0.11 B | 3.87% |
2007 | $0.11 B | 15% |
2006 | $98.67 M | 29.9% |
2005 | $75.96 M | 43.71% |
2004 | $52.85 M | 2.56% |
2003 | $51.54 M | 16.29% |
2002 | $44.32 M | 8.09% |
2001 | $41 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $89.65 B | 4,755.23% | ๐บ๐ธ USA |
Pfizer PFE | $58.49 B | 3,067.74% | ๐บ๐ธ USA |
Amgen AMGN | $28.19 B | 1,426.55% | ๐บ๐ธ USA |
Sanofi SNY | $50.51 B | 2,635.42% | ๐ซ๐ท France |
Merck MRK | $60.11 B | 3,155.31% | ๐บ๐ธ USA |
Bristol-Myers Squibb BMY | $45.53 B | 2,365.77% | ๐บ๐ธ USA |
GlaxoSmithKline GSK | $38.54 B | 1,987.22% | ๐ฌ๐ง UK |
Curis CRIS | $10.02 M | -99.46% | ๐บ๐ธ USA |
AVEO Oncology
AVEO | $94.31 M | -94.89% | ๐บ๐ธ USA |